A clinical endocannabinoid deficiency has been postulated to be operative in certain treatment-resistant conditions (Russo 2004), and has received recent support in findings that anandamide levels are reduced over controls in migraineurs (Sarchielli et al 2006), that a subset of fibromyalgia patients reported significant decreased pain after THC treatment (Schley et al 2006), and the active role of the ECS in intestinal pain and motility in irritable bowel syndrome (Massa and Monory 2006) wherein anecdotal efficacy of cannabinoid treatments have also been claimed.

CBD directly interacts with a number of proteins in the body and central nervous system, a few of which are components of the endogenous cannabinoid system. For instance, CBD binds to both the CB1 and CB2 cannabinoid receptors, but it binds in a way that sets off a reaction that is essentially the opposite of what THC does. CBD is an inverse agonist, while THC is an agonist at CB1. Simply put, CBD is not intoxicating; at the molecular level, it does the opposite of what THC does. Our bodies have several other receptor proteins that participate in the endogenous cannabinoid system (GPR3, GPR6, TRPV1 and TRPV2, for example). CBD binds to all of these, and many of its anti-inflammatory and pain-relieving effects may occur through these pathways.
The market is rife with misinformation even when CBD is sold as a relatively simple oil or supplement. When it’s squirted into a latte or baked into a cookie, CBD’s uses and effects get even more opaque. The chemical’s loudest advocates make health claims far beyond the current scientific evidence, and its harshest critics often dismiss the compound entirely as just another snake oil in America’s long tradition of health scams. Journalists are starting to get a handle on what CBD actually does and what is actually known about it, but along with researchers and regulators, we’re still playing catch-up when it comes to the people who have pushed the compound into what feels like mainstream overnight success: entrepreneurs.
The most pressing need of the hemp industry in North America is for the breeding of more productive oilseed cultivars. At present, mainly European cultivars are available, of which very few are suitable for specialized oilseed production. More importantly, hempseed oil is not competitive, except in the novelty niche market, with the popular food oils. As argued above, to be competitive, hemp should produce approximately 2 t/ha; at present 1 t/ha is considered average to good production. Doubling the productive capacity of a conventional crop would normally be considered impossible, but it needs to be understood just how little hemp has been developed as an oilseed. There may not even be extant land races of the kind of hemp oilseed strains that were once grown in Russia, so that except for a very few very recent oilseed cultivars, there has been virtually no breeding of oilseed hemp. Contrarily, hemp has been selected for fiber to the point that some breeders consider its productivity in this respect has already been maximized. Fiber strains have been selected for low seed production, so that most hemp germplasm has certainly not been selected for oilseed characteristics. By contrast, drug varieties have been selected for very high yield of flowers, and accordingly produce very high yield of seeds. Drug varieties have been observed to produce more than a kilogram of seed per plant, so that a target yield of several tonnes per hectare is conceivable (Watson and Clarke 1997). Of course, the high THC in drug cultivars makes these a difficult source of germplasm. However, wild plants of C. sativa have naturally undergone selection for high seed productivity, and are a particularly important potential source of breeding germplasm.
CBD is able to reduce inflammation in the body by limiting re-uptake of the neurotransmitter adenosine. CBD does this, in part, by inhibiting equilibrative nucleoside transporter 1 (ENT1). By slowing its re-uptake, the amount of adenosine in the brain is increased which in turn impacts the activity of adenosine receptors.  These receptors, particularly the A2A receptor, play a significant role in reducing inflammation throughout the body. 

I totally agree. The greed of the pharmaceutical with their lobbyist to stop the government from making it a schedule III drug so much more research can be done. They do not care about the people, just money. We the people must rise up and let our government know, we care more about our friends and family than the money they give, to you congress men/women and senators get, and we VOTE. The only power we have is writing or calling congress men/women and senators, huge rallies and each and every ones VOTE. They would rather stay in office, than even receive big monies from big pharm for their campaigns. VOTES will win over.
Cannabis has psychoactive and physiological effects when consumed.[45] The immediate desired effects from consuming cannabis include relaxation and euphoria (the "high" or "stoned" feeling), a general alteration of conscious perception, increased awareness of sensation, increased libido[46] and distortions in the perception of time and space. At higher doses, effects can include altered body image, auditory and/or visual illusions, pseudohallucinations and ataxia from selective impairment of polysynaptic reflexes. In some cases, cannabis can lead to dissociative states such as depersonalization[47][48] and derealization.[49]
Via CB1 receptor activation, THC indirectly increases dopamine release and produces psychotropic effects.[146] Cannabidiol (CBD) also acts as an allosteric modulator of the μ- and δ-opioid receptors.[147] THC also potentiates the effects of the glycine receptors.[148] It is unknown if or how these actions contribute to the effects of cannabis.[149]

Probably indigenous to temperate Asia, C. sativa is the most widely cited example of a “camp follower.” It was pre-adapted to thrive in the manured soils around man’s early settlements, which quickly led to its domestication (Schultes 1970). Hemp was harvested by the Chinese 8500 years ago (Schultes and Hofmann 1980). For most of its history, C. sativa was most valued as a fiber source, considerably less so as an intoxicant, and only to a limited extent as an oilseed crop. Hemp is one of the oldest sources of textile fiber, with extant remains of hempen cloth trailing back 6 millennia. Hemp grown for fiber was introduced to western Asia and Egypt, and subsequently to Europe somewhere between 1000 and 2000 BCE. Cultivation in Europe became widespread after 500 ce. The crop was first brought to South America in 1545, in Chile, and to North America in Port Royal, Acadia in 1606. The hemp industry flourished in Kentucky, Missouri, and Illinois between 1840 and 1860 because of the strong demand for sailcloth and cordage (Ehrensing 1998). From the end of the Civil War until 1912, virtually all hemp in the US was produced in Kentucky. During World War I, some hemp cultivation occurred in several states, including Kentucky, Wisconsin, California, North Dakota, South Dakota, Minnesota, Indiana, Illinois, Ohio, Michigan, Kansas, and Iowa (Ehrensing 1998). The second world war led to a brief revival of hemp cultivation in the Midwest, as well as in Canada, because the war cut off supplies of fiber (substantial renewed cultivation also occurred in Germany for the same reason). Until the beginning of the 19th century, hemp was the leading cordage fiber. Until the middle of the 19th century, hemp rivaled flax as the chief textile fiber of vegetable origin, and indeed was described as “the king of fiber-bearing plants,—the standard by which all other fibers are measured” (Boyce 1900). Nevertheless, the Marihuana Tax Act applied in 1938 essentially ended hemp production in the United States, although a small hemp fiber industry continued in Wisconsin until 1958. Similarly in 1938 the cultivation of Cannabis became illegal in Canada under the Opium and Narcotics Act.
To my understanding, neither CBD nor THC are effective for “severe” pain; rather, they work better for mild to moderate chronic pain. Often, with severe pain, the dosage of opiates can be decreased with concomitant use of medical cannabis or CBD and that decrease in dose makes their use safer. Concurrent use of THC does increase the analgesic effect of CBD, but it also adds the “high” which some people do not want as a side effect.
Preliminary research indicates that cannabidiol may reduce adverse effects of THC, particularly those causing intoxication and sedation, but only at high doses.[21] Safety studies of cannabidiol showed it is well-tolerated, but may cause tiredness, diarrhea, or changes in appetite as common adverse effects.[22] Epidiolex documentation lists sleepiness, insomnia and poor quality sleep, decreased appetite, diarrhea, and fatigue.[2]
Cannabis research suggests medical marijuana could become an effective treatment for diabetic neuropathy. Diabetic neuropathy is a debilitating and sometimes fatal condition caused by diabetes. Diabetics suffer from high blood sugar due to insulin resistance, and this damages nerve cells in the body, causing severe pain. Patients who consumed THC as part of a study found they experienced less pain. Findings are not definitive, however, and further research into cannabis as a treatment for diabetes and associated symptoms is required.
You are likely very familiar with the dangers that prescription painkillers (and other pharmaceuticals) present. In fact, it’s estimated that the majority of CBD oil users attempt to switch to the all-natural therapy for the precise reason of kicking prescription med habits, which all too often cause an overwhelming array of irritability, sleep disruption, digestive complications, and even thoughts of suicide.
Grant says this may lead to a “dampening” or mellowing of some neurochemical processes, including those linked to pain. “CBD may also react with other receptors, like those for serotonin, and it may have actions that reduce the inflammatory molecules produced whenever there is tissue damage or bacteria coming in,” he says. “But we really don’t know the mechanisms.”

Hemp seeds contain virtually no THC, but THC contamination results from contact of the seeds with the resin secreted by the epidermal glands on the leaves and floral parts, and also by the failure to sift away all of the bracts (which have the highest concentration of THC of any parts of the plant) that cover the seeds. This results in small levels of THC appearing in hempseed oil and foods made with the seeds. Although most of the western hemp-growing world uses 0.3% THC as a maximum concentration for authorized cultivation of hemp plants, regulations in various countries allow only a much lower level of THC in human food products manufactured from the seeds. Currently, up to 10 ppm THC is permitted in seeds and oil products used for food purposes in Canada. In Germany, more stringent limits were set for food in 2000: 5 ppm in food oil, 0.005 ppm in beverages, and 0.15 ppm in all other foods. The US Drug Enforcement Administration published new regulations on hemp in the Federal Register on October 9th 2001 that in effect 4 months later would ban the food use of hemp in the US because any amount of THC would be unacceptable in foods (follow links at www.hempreport.com/). These proposals are currently being challenged by the hemp industry. Limits have been set because of concerns about possible toxicity and interference with drug tests (Grotenhermen et al. 1998). An extensive analysis of literature dealing with the toxicity of hemp is in Orr and Starodub (1999; see Geiwitz 2001 for an analysis). Because hemp food products are considered to have great economic potential, there is considerable pressure on the hemp industry in North America to reduce THC levels. 

When suffering from chronic pain, it can be difficult to find lasting and effective pain relief. Taking CBD oil for pain can be the perfect solution, especially when you consider how bleak the other options can appear. You can suffer through medications that do not provide enough relief, or, you can take a variety of prescribed pharmaceuticals that can carry significant side effects that can further diminish your health and quality of life.
Despite the fact that Cannabis was grown on a large scale in many countries, the abuse as a narcotic remained uncommon in Western countries until relatively recently. People were largely unaware of the psychoactive properties of Cannabis and it is unlikely that early cultivars, selected mainly for their seed or fiber qualities, contained significant amounts of the psychoactive THC. The medicinal use of Cannabis was introduced in Europe only around 1840, by a young Irish doctor, William O’Shaughnessy, who served for the East India Trading Company in India, where the medicinal use of Cannabis was widespread. Unlike the European fiber Cannabis, these Indian varieties did contain a reasonable amount of bioactive cannabinoids. In the following decades, the medicinal use of Cannabis saw a short period of popularity both in Europe and in the United States. At the top of its popularity, more than 28 different medicinal preparations were available with Cannabis as active ingredient, which were recommended for indications as various as menstrual cramps, asthma, cough, insomnia, support of birth labor, migraine, throat infection, and withdrawal from opium use.27
The 2014 Farm Bill[75] legalized the sale of "non-viable hemp material" grown within states participating in the Hemp Pilot Program.[76] This legislation defined hemp as cannabis containing less than 0.3% of THC delta-9, grown within the regulatory framework of the Hemp Pilot Program.[77] The 2018 Farm Bill allowed for interstate commerce of hemp derived products, though these products still fall under the purview of the FDA.[78][79]
Cannabis has an ancient history of ritual use and is found in pharmacological cults around the world. Hemp seeds discovered by archaeologists at Pazyryk suggest early ceremonial practices like eating by the Scythians occurred during the 5th to 2nd century BC, confirming previous historical reports by Herodotus.[202] It was used by Muslims in various Sufi orders as early as the Mamluk period, for example by the Qalandars.[203] Smoking pipes uncovered in Ethiopia and carbon-dated to around c. AD 1320 were found to have traces of cannabis.[204]

Jackson Leyden had always been a healthy kid; he practiced taekwondo, and he played lacrosse and baseball. But in 2011, a few months after his eighth birthday, he began having seizures several times a day. Many were brief, a half-minute of staring into space, but he also had severe episodes in which he would collapse, sometimes injuring himself. Over the next two years, he was hospitalized about 50 times, and he missed much of fourth and fifth grade.
Hemp is possibly one of the earliest plants to be cultivated.[109][110] An archeological site in the Oki Islands near Japan contained cannabis achenes from about 8000 BC, probably signifying use of the plant.[111] Hemp use archaeologically dates back to the Neolithic Age in China, with hemp fiber imprints found on Yangshao culture pottery dating from the 5th millennium BC.[108][112] The Chinese later used hemp to make clothes, shoes, ropes, and an early form of paper.[108] The classical Greek historian Herodotus (ca. 480 BC) reported that the inhabitants of Scythia would often inhale the vapors of hemp-seed smoke, both as ritual and for their own pleasurable recreation.[113]
Cannabis, also known as marijuana among other names,[a] is a psychoactive drug from the Cannabis plant used for medical or recreational purposes.[16][17][18] The main psychoactive part of cannabis is tetrahydrocannabinol (THC), one of 483 known compounds in the plant,[19] including at least 65 other cannabinoids.[20] Cannabis can be used by smoking, vaporizing, within food, or as an extract.[21]
With marijuana, apparently, we’re still waiting for this information. It’s hard to study a substance that until very recently has been almost universally illegal. And the few studies we do have were done mostly in the nineteen-eighties and nineties, when cannabis was not nearly as potent as it is now. Because of recent developments in plant breeding and growing techniques, the typical concentration of THC, the psychoactive ingredient in marijuana, has gone from the low single digits to more than twenty per cent—from a swig of near-beer to a tequila shot.
“Specialty pulp” is the most important component of the hemp industry of the EU, and is expected to remain its core market for the foreseeable future. The most important specialty pulp products made from hemp are cigarette paper (Fig. 16), bank notes, technical filters, and hygiene products. Other uses include art papers and tea bags. Several of these applications take advantage of hemp’s high tear and wet strength. This is considered to be a highly stable, high-priced niche market in Europe, where hemp has an 87% market share of the “specialty pulp” sector (Karus et al. 2000). In Europe, decortication/refining machines are available that can produce 10 t/hour of hemp fiber suitable for such pulp use. North American capacity for hemp pulp production and value-added processing is much more limited than that of Europe, and this industry is negligible in North America.
When privacy isn’t a requirement, outdoor cannabis grows can provide many advantages over indoor operations. Sunlight is the single most important factor for successful outdoor marijuana growing. It’s important to choose a plot with total sunshine throughout the day. Therefore, cannabis growers in the northern hemisphere will want plots with southern exposure, exposing marijuana plants to the sun’s arc across the sky.

The Drug Enforcement Agency and the Office of National Drug Control Policy of the US raised concerns over tests conducted from 1995 to 1997 that showed that consumption of hempseed products available during that period led to interference with drug-testing programs for marijuana use. Federal US programs utilize a THC metabolite level of 50 parts per billion in urine. Leson (2000) found that this level was not exceeded by consuming hemp products, provided that THC levels are maintained below 5 ppm in hemp oil, and below 2 ppm in hulled seeds. Nevertheless the presence of even minute trace amounts of THC in foods remains a tool that can be used by those wishing to prevent the hemp oilseed industry from developing.

Fig. 11. Frequency histograms of THC concentration in germplasm collections. Left, collection of E. Small and D. Marcus; of the 167 accessions, 43% had THC levels >0.3%. Right, the collection of the Vavilov Institute, St. Petersburg; of the 278 accessions for which chemical analyses were reported in Anonymous (1975), about 55% had THC levels >0.3%.

Cannabinoids are divided into three groups. The first are naturally occurring 21-carbon terpenophenolic compounds found to date solely in plants of the Cannabis genus, currently termed phytocannabinoids (Pate 1994). The best known analgesic of these is Δ9-tetrahydrocannabinol (henceforth, THC)(Figure 1), first isolated and synthesized in 1964 (Gaoni and Mechoulam 1964). In plant preparations and whole extracts, its activity is complemented by other “minor” phytocannabinoids such as cannabidiol (CBD) (Figure 1), cannabis terpenoids and flavonoids, as will be discussed subsequently.